Lab report (Certificate of Analysis, COA)

CJC No DAC IPA Blend · 5mg each (10mg total)

Batch 1684 · tested June 1, 2026 (159 days ago) · released July 15, 2026

All tests passed

Batch: #1684 14 of 15 tests
Mass: 5mg each (10mg total)
Purity: 99.30%
Issuing lab accreditation: Vanguard · ISO 17025:2017 / A2LA #6377.01.01

3 units tested for purity: 99.30 / 99.31 / 99.30% · spread 0.01 pt · net peptide content · ipamorelin 5.23 / 5.13 / 5.26 mg · net peptide content · cjc-1295 5.03 / 4.96 / 5.00 mg

Conformity: Units agree — every reported unit passed on all 12 test rows · purity spread 0.01 pt within the house limit · content spread (Ipamorelin) 2.5% within the house limit · content spread (CJC-1295) 1.4% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-06-01

Vanguard · issuing labEagle Analytical · sterility

Lab report (PDF)
Download

Verified by Vanguard Laboratory

This certificate is also hosted by Vanguard Laboratory — the issuing lab — on its own verification site.

View on VerifiedByVanguard.com
Laboratory ID V260515-17 001

Notes

Content audit 9 Sep 2026: product #564 CJC-1295 No DAC → #548 CJC No DAC IPA Blend; size 24495 → #686 5mg-each-10mg-total. Certificate prints: prints compound "CJC-1295 no DAC/Ipamorelin", lot "1684", lab id "V260515-17 001", content Ipamorelin: 5.23 / 5.13 / 5.26 mg; CJC-1

Reports for this lot

Vanguard Laboratory this report · tested June 1, 2026 · 12 results · QA approvalVanguard · issuing labEagle Analytical · sterilityAll tests passed

Test by test

12 results on the report · 4 rows computed from the per-unit values · 2 labs · each test used up to 5 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows

✓PurityWithin limits

avg 99.30% · 3 units · USP <621> (procedural chapter)

✓Purity consistency between unitsWithin house limit

3 units: 99.30 / 99.31 / 99.30% · spread 0.01 pt · house limit · caution past 0.50 pt, outside past 1.00 pt · per-unit USP <621> results

✓Net peptide content (assay) · IpamorelinWithin limits

avg 5.21 mg · 3 units · USP <621> (procedural chapter)

✓Net peptide content (assay) · CJC-1295Within limits

avg 5.00 mg · 3 units · USP <621> (procedural chapter)

✓Content consistency between units · IpamorelinWithin house limit

3 units: 5.23 / 5.13 / 5.26 mg · spread 0.13 mg, 2.5% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)

✓Content consistency between units · CJC-1295Within house limit

3 units: 5.03 / 4.96 / 5.00 mg · spread 0.07 mg, 1.4% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)

✓Heavy metalsWithin limits

5 elements non-detect · 2 units · dose-scaled limits derived from USP <232> (limits chapter)

Element	Measured	Limit	Verdict
Chromium (Cr)	ND (<0.05 ppm)	1,100,000 ppm	Not detected
Arsenic (As)	ND (<0.01 ppm)	15,000 ppm	Not detected
Cadmium (Cd)	ND (<0.01 ppm)	2,000 ppm	Not detected
Lead (Pb)	ND (<0.02 ppm)	5,000 ppm	Not detected
Mercury (Hg)	ND (<0.01 ppm)	3,000 ppm	Not detected

Dose-scaled limits derived from USP <232> for arsenic, cadmium, lead, mercury and chromium, using this product's configured reference quantity of 1.00 mg.

✓Residual solventsWithin limits

all non-detect · 1 unit · USP <467> (procedural chapter)

✓Trifluoroacetic acidWithin limits

all non-detect · 1 unit · house limit · ion chromatography, the lab's method; no compendial chapter for the method run · limit <0.10% (the lab's)

✓EndotoxinsPass

3 of 3 pass · 3 units · USP <85> (procedural chapter) · limit <5.00 EU/mg (the lab's)

✓Container closurePass

3 of 3 pass · 3 units · USP <1207> (informational chapter (1000-series))

✓SolubilityPass

3 of 3 pass · 3 units · house check · no compendial chapter

✓SterilityPass

5 of 5 pass · 5 units · USP <71> (procedural chapter)

✓SterilityPass

1 of 1 pass · 1 unit · USP <71> (reference) · a rapid viability test used as an alternative to the USP <71> growth test; USP <1223> is the validation framework (informational chapter) · at Eagle Analytical

✓Other · Adulterant screenWithin limits

all non-detect · 1 unit · no chapter named in the record; a screen

✓ConformityUnits agree

every reported unit passed on all 12 test rows · purity spread 0.01 pt within the house limit · content spread (Ipamorelin) 2.5% within the house limit · content spread (CJC-1295) 1.4% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-06-01 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Combined report · Batch 1684

One file holding the Vanguard Laboratory and Eagle Analytical Services reports for this batch, combined by our system from the labs' own files.

4 pages · Vanguard report V260515-17 001

Open PDF
Download